ScreenerHero

LONA LeonaBio, Inc.

NAS · US · Healthcare · Biotechnology · leonabio.com
5.830USD+1.39%Mkt Cap: 54.93M $P/E: —

LeonaBio, Inc., clinical-stage biopharmaceutical company, engages in the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral scle…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap54.93M USD
Enterprise Value2.08M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-105.61M USD
Revenue/Share—
Last Price5.830 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees19
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.04
EV/Revenue—
P/S—
P/B1.61
EPS (TTM)-23.01
EPS (Forward)—
52W Range
2.21030% of range14.21
52W High14.21 USD
52W Low2.210 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-380.03%
ROA-114.60%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-45.73M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-42.13%
Net Debt-50.49M USD
Net Debt/EBITDA0.94
Balance Sheet
Debt/Equity0.03
Current Ratio7.01
Quick Ratio6.53
Book Value/Sh3.57 USD
Cash/Share5.42 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateSep 18, 2025
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)17.33 USD
Upside (mean)+197.3%
Target Range15.00 USD – 20.00 USD
15.00+197.3% to mean20.00
# Analysts3
Ownership
Shares Out.9.42M
Float4.73M
Insiders4.07%
Institutions87.66%
Short Interest
Short Ratio0.3d
Short % Float0.32%
Short % Out.0.25%
Shares Short23.65K
Short (prev mo.)38.97K
Technical
SMA 506.902 (-15.5%)
SMA 2007.656 (-23.8%)
Beta2.12
S&P 52W Chg16.45%
Avg Vol (30d)341.98K
Avg Vol (10d)890.74K
Technical Indicators
RSI (14)49.6
MACD-0.6175
MACD Signal-0.7673
MACD Hist.+0.1498
BB Upper8.689 USD
BB Middle5.658 USD
BB Lower2.627 USD
BB Width107.12%
ATR (14)0.8803 USD
Vol Ratio (20d)0.37x